Resources

July 10, 2025

AstraZeneca Partners With Genemod to Improve Bioprocess Development

Astrazeneca-Genemod-Case-Study
Research focus

Biotechnology

Institution

AstraZeneca

Lab size

83,500

Overview

AstraZeneca is a multinational pharmaceutical and biotechnology company with a significant presence in the biotech and life sciences industry. Its main focus areas in the pharmaceutical and biotechnology industry encompass a wide range of therapeutic areas and medical research, such as Oncology, CVRM, Respiratory, Immunology, Neuroscience, Infectious Diseases, and many more scientific fields.

The primary goal of this case study is to share the specific challenges a global biotechnology company faced and how they successfully addressed them by adopting Genemod, a modern and comprehensive Laboratory Information Management System (LIMS). This case study will provide better insights into the implementation of Genemod, its impact on laboratory operations, and its broader implications for scientific research.

Astrazeneca-Genemod-Quote-01

Scope And Challenges

1. Data management and integration

AstraZeneca needed a cohesive solution for managing diverse, multifarious research data, aiming for real-time, reliable access across various domains to spur innovation and accelerate research processes.

2. Inventory search speed and efficiency

A sophisticated, responsive system was crucial for AstraZeneca to navigate their extensive, evolving inventory, enhance lab efficiency, and allow researchers to focus more on core research activities.

3. Data security and compliance

In the strictly regulated industry, a stringent security and compliance framework was essential for AstraZeneca to mitigate potential risks and legal ramifications related to data breaches and noncompliance.

Approach

1. Deploy Advanced Data Integration

Embracing Genemod’s lab management solutions marked a pivotal turn for AstraZeneca. Genemod meticulously developed and deployed an integrationcentric approach,  everaging secure cloud technologies to consolidate diverse data sources. This approach not only assured heightened data security and integrity but also allowed seamless and synchronized access to integrated data across the teammates.

2. Optimize Inventory Management

With Genemod’s inventory management solutions, AstraZeneca achieved substantial improvements in inventory search and lab efficiency. The transformation was noticeable as the well-structured and standardized workflow, complemented by the advanced search feature, considerably shortened the time required to locate and manage inventory items. This swift implementation was welcomed and rapidly adopted by the team members, enhancing overall lab productivity.

3. Leverage Real-time Data Entry and Traceability

AstraZeneca leveraged Genemod’s capabilities to ensure real-time data entries and traceability, allowing the researchers to track and access the historical modifications and alterations in the data seamlessly. This feature is quintessential for maintaining data integrity and facilitating transparent and accurate research documentation.

4. Ensuring Compliance and Security

Genemod’s comprehensive security and compliance management solutions were instrumental in helping AstraZeneca maintain rigorous standards of data security and ensure adherence to all regulatory guidelines, thereby mitigating any risks associated with non-compliance and potential data breaches. security and enabled dispersed access to the lab’s inventory.

5. Facilitate Collaborative Research

Genemod’s solutions were optimized to foster collaborative research efforts within AstraZeneca. Enhanced communication and shared resources facilitated by Genemod empowered teams to synergize and innovate more effectively, breaking down silos and enabling cross-functional collaboration across different research domains.

6. Implement User-friendly Interfaces

Genemod developed intuitive, user-friendly interfaces for scientific laboratories, ensuring quick adoption and minimal learning curves for researchers. The ease of use encouraged more widespread utilization of the system, allowing researchers to focus on their work rather than navigating complex software environments.

7. Enhance Customization and Scalability

Genemod provided highly customizable and scalable solutions to meet AstraZeneca’s diverse and evolving needs. The adaptability of the system allowed AstraZeneca to tailor the software to their unique research requirements and scale the solutions as needed, ensuring long-term viability and relevance.

8. Empower Decision-Making Through Analytics

By integrating advanced Electronic Lab Notebook (ELN) with the innovative Genemod AI feature, Genemod enabled AstraZeneca to glean actionable insights from their data. This approach empowered researchers and decision-makers with the necessary information to make informed, data-driven decisions, optimizing research outcomes and operational efficiency.

Astrazeneca-Genemod-ROI

Impact

The integration of Genemod at AstraZeneca has had a transformative impact, reshaping the research landscape by ensuring optimal data management, advanced real-time traceability, enhanced security, regulatory compliance, and many more. AstraZeneca experienced a surge in productivity, and the refined workflows enabled a sharper focus on innovative research endeavors, accelerating the pace of discovery and development in their varied therapeutic domains.

The journey of AstraZeneca with Genemod illustrates the transformative potential of specialized lab information management systems in refining operational workflows, securing data, and accelerating research in large-scale, multifaceted research environments.
The successful collaboration of Genemod’s cutting-edge solutions within AstraZeneca’s diverse research landscape exemplifies in this case study demonstrates the potential benefits of specialized LIMS solutions for research laboratories. It underscores how such systems can lead to increased efficiency, improved data security, and the capacity to pursue more ambitious research goals.

Astrazeneca-Genemod-Quote-03